Two great examples are Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) and Vertex Pharmaceuticals (NASDAQ: VRTX). Warren ...

SINGAPORE] Over the five trading sessions from May 23 to May 29, institutions were marginal net sellers of Singapore stocks, ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals Inc. closed 14.97% short of its 52-week high of $519.88, which the company achieved on November 8th.

Cofounder John Donohue is stepping down on May 31 from his job as chief executive. He’ll still chair the company’s board and ...

UBS analyst Eliana Merle reaffirmed a Buy rating and a $582 price target for Vertex Pharmaceuticals, praising the adoption of ...

The AI agents mark a significant milestone as a direct outcome of the Google Cloud C enter of E xcellence, powered by Infosys Topaz™. The initiative leverages the advanced AI capabilities of Infosys ...

Vertex Pharmaceuticals is riding high on analyst confidence, thanks to its leadership in NAV1.8 inhibitors and smart partnerships. Jefferies analyst Michael Yee recently reaffirmed a Buy rating, ...

Vertex has built its earnings thanks to its CF program, and with a new CF drug approved a few months ago, the company may be ...

Reshma Kewalramani, Bela Bajaria, Revathi Advaithi and Meena Lakdawala Flynn among women at the top of the global business ...